The outcomes and treatment strategies in metastatic soft tissue sarcoma treated with immunotherapy-based therapy: a three-center study.

Front Immunol · 2025 · PMC11985850 · PMID 40226622

Europe PMC DOI

hedged sentence

0.0200

closest p · 0.4× alpha

0.0200

boldest claim

The sentences

showed a trendP =0.02actually significant

The results showed a trend of survival benefit for potentially sensitive sarcomas compared to others in terms of PFS ( P =0.02) and OS ( P =0.03) ( Figures 2E, F ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.